Recent News

• 02.27.2026 - OPKO Health to Participate in the Jefferies Biotech on the Beach Summit
• 02.27.2026 - OPKO Health to Participate in the Jefferies Biotech on the Beach Summit
• 02.26.2026 - OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results
• 02.26.2026 - OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results
• 02.12.2026 - OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26
• 02.12.2026 - OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26
• 02.04.2026 - OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism
• 02.04.2026 - OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism
• 01.06.2026 - OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference
• 01.06.2026 - OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Recent Filings

• 02.26.2026 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.26.2026 - EX-99.1 EX-99.1
• 02.26.2026 - 8-K Current report
• 11.21.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.18.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.31.2025 - 4 Statement of changes in beneficial ownership of securities